Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.
Bringing fresh perspectives to long-standing health challenges, these scientists are using techniques such as big-data analytics and AI to push the field.
A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at natureindex.com.
Precision medicine and artificial intelligence are major trends in healthcare and biomedical research. The Medical University of Vienna is embarking on an ambitious expansion to enhance its research and clinical capabilities.
MD Anderson leads the way in combining microbiome insights with cancer therapy, revealing how dietary interventions can transform patient outcomes and advance precision medicine.
A global leader in eye health, the Singapore Eye Research Institute, is battling to address the problem of short-sightedness, and is using AI to speed up disease screenings.
Families of paediatric cancer patients have helped move a pioneering treatment for neuroblastoma from the lab to the clinic. Could this breakthrough accelerate the development of future treatments?
Artificial intelligence focused on dynamic patient care is helping to fine-tune drug dosing regimes and reduce hospital wait times, with potentially dramatic benefits.
The progression of chronic kidney disease can take patients and doctors by surprise. But if public awareness about the risks of this potential killer changes, the prognosis for patients could too.
The efficacy and safety of a treatment is best confirmed in the real world through post-marketing data collection according to pharmaceutical company Alexion Japan.
How does the brain control how much we eat, and — conversely — how does the gut impact our brain health? Researchers are revealing some interesting findings.